Neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease share the pathological hallmark of fibrillar protein aggregates. The identification of novel small compounds that bind fibrillar protein aggregates has been a challenge. MST is a powerful and practical methodology to quantify interactions between small molecules and protein fibrillar aggregates.